Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily C Zabor

Showing results (61-70 of 167) with videos related to

Pageof 17
Sort By:
Breast Cancer Research and Treatment|January 16, 2020
Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomyAudree B Tadros, Tracy-Ann Moo, Michelle Stempel, et al.
Annals of Surgical Oncology|March 1, 2019
Chemoprevention Uptake for Breast Cancer Risk Reduction Varies by Risk FactorMeghan R Flanagan, Emily C Zabor, Michelle Stempel, et al.
Ophthalmology|January 17, 2017
Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year ExperienceJasmine H Francis, Scott E Brodie, Brian Marr, et al.
Clinical Breast Cancer|June 20, 2025
Disparities in Access to Multigene Testing in Early-Stage, HR-positive, HER2-negative, Lymph Node-negative Breast CancerMaría Herrán, Emily C Zabor, Saad Sabbagh, et al.
Statistics in Medicine|July 17, 2013
A conceptual and methodological framework for investigating etiologic heterogeneityColin B Begg, Emily C Zabor, Jonine L Bernstein, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2019
Evidence for Etiologic Subtypes of Breast Cancer in the Carolina Breast Cancer StudyHalei C Benefield, Emily C Zabor, Yue Shan, et al.
Cancer|October 12, 2018
Does nonmetastatic inflammatory breast cancer have a worse prognosis than other nonmetastatic T4 cancers?Anya Romanoff, Emily C Zabor, Oriana Petruolo, et al.
Annals of Surgical Oncology|August 9, 2020
Does Use of Neoadjuvant Chemotherapy Affect the Decision to Pursue Fertility Preservation Options in Young Women with Breast Cancer?Angelena Crown, Shirin Muhsen, Emily C Zabor, et al.
Cancer Medicine|May 15, 2015
Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast CancerColin B Begg, Irene Orlow, Emily C Zabor, et al.
Annals of Surgical Oncology|September 28, 2019
The Tyrer-Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCISMonica G Valero, Emily C Zabor, Anna Park, et al.
Pageof 17

Showing results (61-70 of 167) with videos related to

Sort By:
Pageof 17
Breast Cancer Research and Treatment|January 16, 2020
Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomyAudree B Tadros, Tracy-Ann Moo, Michelle Stempel, et al.
Annals of Surgical Oncology|March 1, 2019
Chemoprevention Uptake for Breast Cancer Risk Reduction Varies by Risk FactorMeghan R Flanagan, Emily C Zabor, Michelle Stempel, et al.
Ophthalmology|January 17, 2017
Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year ExperienceJasmine H Francis, Scott E Brodie, Brian Marr, et al.
Clinical Breast Cancer|June 20, 2025
Disparities in Access to Multigene Testing in Early-Stage, HR-positive, HER2-negative, Lymph Node-negative Breast CancerMaría Herrán, Emily C Zabor, Saad Sabbagh, et al.
Statistics in Medicine|July 17, 2013
A conceptual and methodological framework for investigating etiologic heterogeneityColin B Begg, Emily C Zabor, Jonine L Bernstein, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2019
Evidence for Etiologic Subtypes of Breast Cancer in the Carolina Breast Cancer StudyHalei C Benefield, Emily C Zabor, Yue Shan, et al.
Cancer|October 12, 2018
Does nonmetastatic inflammatory breast cancer have a worse prognosis than other nonmetastatic T4 cancers?Anya Romanoff, Emily C Zabor, Oriana Petruolo, et al.
Annals of Surgical Oncology|August 9, 2020
Does Use of Neoadjuvant Chemotherapy Affect the Decision to Pursue Fertility Preservation Options in Young Women with Breast Cancer?Angelena Crown, Shirin Muhsen, Emily C Zabor, et al.
Cancer Medicine|May 15, 2015
Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast CancerColin B Begg, Irene Orlow, Emily C Zabor, et al.
Annals of Surgical Oncology|September 28, 2019
The Tyrer-Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCISMonica G Valero, Emily C Zabor, Anna Park, et al.
Pageof 17